<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://paxton.app/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://paxton.app/paxton-digital-announces-venture-capital-fundraising-efforts-and-public-market-readiness-initiative/</loc><lastmod>2026-07-26T18:31:24-04:00</lastmod></url><url><loc>https://paxton.app/ai-infrastructure-power-token-business/</loc><lastmod>2026-09-30T17:19:40-04:00</lastmod></url><url><loc>https://paxton.app/paxton-scout-introduces-prognosis-ip-market-clinical-outlook/</loc><lastmod>2026-10-28T17:56:02-04:00</lastmod></url><url><loc>https://paxton.app/daniel-strickland-featured-artist/</loc><lastmod>2026-10-28T17:56:15-04:00</lastmod></url><url><loc>https://paxton.app/healthcare-deals-option-care-mckesson-cdr-home-infusion/</loc><lastmod>2026-10-28T17:56:14-04:00</lastmod></url><url><loc>https://paxton.app/steris-xodus-medical-2-1-billion-acquisition/</loc><lastmod>2026-10-28T17:56:13-04:00</lastmod></url><url><loc>https://paxton.app/iambic-city-therapeutics-biotech-ipo-window/</loc><lastmod>2026-10-28T17:56:12-04:00</lastmod></url><url><loc>https://paxton.app/rush-endeavor-merger-11-billion-health-system-margins/</loc><lastmod>2026-10-28T17:56:10-04:00</lastmod></url><url><loc>https://paxton.app/iambic-therapeutics-ipo-ai-drug-discovery-nasdaq/</loc><lastmod>2026-10-28T17:56:09-04:00</lastmod></url><url><loc>https://paxton.app/risant-health-integris-kaiser-oklahoma-2026/</loc><lastmod>2026-10-25T16:35:50-04:00</lastmod></url><url><loc>https://paxton.app/hospital-mergers-2026-pass-2025-kaufman-hall/</loc><lastmod>2026-10-26T04:16:51-04:00</lastmod></url><url><loc>https://paxton.app/alcon-neurotech-550-million-encelto/</loc><lastmod>2026-10-28T17:56:07-04:00</lastmod></url><url><loc>https://paxton.app/rush-and-endeavor-plan-a-12-hospital-11-billion-chicago-system-targeting-an-early-2027-close/</loc><lastmod>2026-10-28T16:27:53-04:00</lastmod></url><url><loc>https://paxton.app/gilead-pays-up-to-1-9-billion-for-virs-t-cell-engagers-as-pharma-keeps-buying-oncology-pipelines/</loc><lastmod>2026-10-28T16:27:35-04:00</lastmod></url><url><loc>https://paxton.app/open-enrollment-2027-compare-health-plans-total-yearly-cost/</loc><lastmod>2026-10-28T17:56:06-04:00</lastmod></url><url><loc>https://paxton.app/lycia-therapeutics-318-million-ipo-lyca-nasdaq-debut/</loc><lastmod>2026-10-26T10:07:33-04:00</lastmod></url><url><loc>https://paxton.app/healthspan-partners-bon-secours-surgery-partners-5-7-billion/</loc><lastmod>2026-10-28T07:37:17-04:00</lastmod></url><url><loc>https://paxton.app/aspen-neuroscience-bambusa-therapeutics-ipo-150-million-nasdaq/</loc><lastmod>2026-10-29T07:13:17-04:00</lastmod></url><url><loc>https://paxton.app/viatris-pacira-tender-offer-november-16/</loc><lastmod>2026-10-31T22:05:06-04:00</lastmod></url><url><loc>https://paxton.app/private-equity-hospital-count-561-select-medical-massachusetts-review/</loc><lastmod>2026-11-01T07:12:03-05:00</lastmod></url></urlset>
